Search research articles
Contact Us
Filters
Showing results (51-60 of 173) with videos related to
Page
of 18
Sort By:
Expert Opinion on Drug Metabolism & Toxicology
|
July 20, 2010
Benefits from pharmacological and pharmacokinetic properties of sunitinib for clinical development
Marie-Paule Sablin, Chantal Dreyer, Camelia Colichi, et al.
Journal of Insurance Medicine (New York, N.Y.)
|
September 19, 2023
Methods for Inclusive Underwriting of Breast Cancer Risk with Machine Learning and Innovative Algorithms
Manuel Plisson, Antoine Moll, Valentine Sarrazin, et al.
Journal of Hepatology
|
December 15, 2010
Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma
Hélène Marijon, Safi Dokmak, Valérie Paradis, et al.
Journal of Insurance Medicine (New York, N.Y.)
|
September 18, 2025
Prostate Cancer Insurability: Population Identification Within the Insurability Corridor and the Right to be Forgotten
Antoine Moll, Eric Raymond, Théo Schneider, et al.
Cancer Chemotherapy and Pharmacology
|
December 7, 2014
Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors
Daniel Castellano, Enrique Grande, Juan Valle, et al.
American Journal of Translational Research
|
July 31, 2014
Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis
Ismael Ghanem, Maria E Riveiro, Valerie Paradis, et al.
Investigational New Drugs
|
September 19, 2007
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors
Catherine Delbaldo, Eric Raymond, Karina Vera, et al.
Pharmacology & Therapeutics
|
December 3, 2014
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Romain Cohen, et al.
International Journal of Oncology
|
July 16, 2002
Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells
Eric Raymond, Christophe Louvet, Christophe Tournigand, et al.
World Journal of Gastroenterology
|
September 24, 2011
Gemcitabine in elderly patients with advanced pancreatic cancer
Olivia Hentic, Chantal Dreyer, Vinciane Rebours, et al.
Page
of 18
Search research articles
Search
Showing results (51-60 of 173) with videos related to
Sort By:
Page
of 18
Expert Opinion on Drug Metabolism & Toxicology
|
July 20, 2010
Benefits from pharmacological and pharmacokinetic properties of sunitinib for clinical development
Marie-Paule Sablin, Chantal Dreyer, Camelia Colichi, et al.
Journal of Insurance Medicine (New York, N.Y.)
|
September 19, 2023
Methods for Inclusive Underwriting of Breast Cancer Risk with Machine Learning and Innovative Algorithms
Manuel Plisson, Antoine Moll, Valentine Sarrazin, et al.
Journal of Hepatology
|
December 15, 2010
Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma
Hélène Marijon, Safi Dokmak, Valérie Paradis, et al.
Journal of Insurance Medicine (New York, N.Y.)
|
September 18, 2025
Prostate Cancer Insurability: Population Identification Within the Insurability Corridor and the Right to be Forgotten
Antoine Moll, Eric Raymond, Théo Schneider, et al.
Cancer Chemotherapy and Pharmacology
|
December 7, 2014
Expert consensus for the management of advanced or metastatic pancreatic neuroendocrine and carcinoid tumors
Daniel Castellano, Enrique Grande, Juan Valle, et al.
American Journal of Translational Research
|
July 31, 2014
Insights on the CXCL12-CXCR4 axis in hepatocellular carcinoma carcinogenesis
Ismael Ghanem, Maria E Riveiro, Valerie Paradis, et al.
Investigational New Drugs
|
September 19, 2007
Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors
Catherine Delbaldo, Eric Raymond, Karina Vera, et al.
Pharmacology & Therapeutics
|
December 3, 2014
Targeting the TGFβ pathway for cancer therapy
Cindy Neuzillet, Annemilaï Tijeras-Raballand, Romain Cohen, et al.
International Journal of Oncology
|
July 16, 2002
Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells
Eric Raymond, Christophe Louvet, Christophe Tournigand, et al.
World Journal of Gastroenterology
|
September 24, 2011
Gemcitabine in elderly patients with advanced pancreatic cancer
Olivia Hentic, Chantal Dreyer, Vinciane Rebours, et al.
Page
of 18